EGFR and lung adenocarcinoma: [39] Riediger Riediger AL AL Dietz Dietz S S Schirmer Schirmer U U Meister Meister M M Heinzmann-Groth Heinzmann-Groth I I Schneider Schneider M M Muley Muley T T Thomas Thomas M M Sültmann Sültmann H H Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients Sci Rep Sci Rep 2016 2016 6 6 33505 33505 27640882 27640882